Roivant Sciences Ltd.'s Net Worth

$2.08 Billion

Estimate Recalculated Feb 23, 2024 04:32PM EST

Who is Roivant Sciences Ltd.?

Roivant Sciences Ltd. has an estimated net worth of $2.08 Billion. This is based on reported shares across multiple companies, which include Immunovant, Inc., Urovant Sciences Ltd., Myovant Sciences Ltd., Axovant Gene Therapies Ltd., and Arbutus Biopharma Corp.

SEC CIK

Roivant Sciences Ltd.'s CIK is 0001635088

Past Insider Trading and Trends

2019 was Roivant Sciences Ltd.'s most active year for acquiring shares with 41 total transactions. Roivant Sciences Ltd.'s most active month to acquire stocks was the month of May. 2019 was Roivant Sciences Ltd.'s most active year for disposing of shares, totalling 2 transactions. Roivant Sciences Ltd.'s most active month to dispose stocks was the month of November. 2019 saw Roivant Sciences Ltd. paying a total of $464,420,505.98 for 50,420,225 shares, this is the most they've acquired in one year. In 2019 Roivant Sciences Ltd. cashed out on 67,868,617 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Immunovant, Inc. (IMVT) Snapshot price: $35.265

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+8.13%
6M
$38.00
$228,000,000.00
79.81M
Oct 2
Form 4
+0.57%
416.67K
$6.00
$2,500,002.00
73.81M
Oct 6
Form 4
+30.20%
17.02M
73.39M
Aug 2
Form 4
+18.44%
8.77M
56.37M
Sep 17
Form 4
+0.80%
380K
$33.00
$12,540,000.00
47.59M
Sep 4
Form 4
+22.83%
8.77M
47.21M
May 12
Form 4
+2.77%
1.03M
$14.50
$15,000,003.50
38.44M
Apr 16
Form 4
+7,612.36%
36.92M
$10.00
$369,199,670.00
37.4M
Dec 18
Form 3
0
0
No matching records found

Urovant Sciences Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-22.86M
0
Dec 27
Form 4
+0.08%
18.2K
$8.32
$151,380.99
22.86M
Scheduled
Jun 17 - Jun 19
Form 4
+0.10%
22.01K
$8.06
$177,300.64
22.84M
Scheduled
Jun 12 - Jun 14
Form 4
+0.09%
21.34K
$8.31
$177,247.38
22.82M
Scheduled
Jun 7 - Jun 11
Form 4
+0.09%
21.12K
$7.86
$165,950.15
22.8M
Scheduled
Jun 4 - Jun 6
Form 4
+0.08%
17.75K
$7.83
$138,946.36
22.78M
Scheduled
May 30 - Jun 3
Form 4
+0.06%
14.48K
$7.63
$110,461.18
22.76M
Scheduled
May 24 - May 29
Form 4
+0.09%
19.83K
$8.22
$162,918.35
22.75M
Scheduled
May 21 - May 23
Form 4
+0.10%
21.61K
$7.54
$162,884.29
22.73M
May 16 - May 20
Form 4
+13.38%
2.68M
$14.00
$37,499,994.00
22.7M
Oct 1
Form 3
0
0
No matching records found

Myovant Sciences Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-45.01M
0
Dec 27
Form 4
+0.55%
245K
$15.38
$3,767,705.89
45.01M
Dec 16 - Dec 17
Form 4
+0.57%
254.19K
$18.03
$4,584,355.61
44.76M
Dec 2 - Dec 4
Form 4
+8.53%
3.5M
$15.00
$52,500,000.00
44.51M
Nov 25
Form 4
+0.60%
243.81K
$12.39
$3,021,688.14
41.01M
Nov 20 - Nov 21
Form 4
+6.32%
2.42M
$8.25
$19,999,996.50
40.77M
Jun 4
Form 4
+2.98%
1.11M
$20.27
$22,500,004.05
38.34M
Apr 2
Form 3
0
0
No matching records found

Axovant Gene Therapies Ltd. (SIOX) Snapshot price: $0.475

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+40.27%
5.33M
$3.75
$19,999,998.75
18.58M
Feb 24
Form 4
+6.71%
6.67M
$1.50
$10,000,000.50
105.95M
Mar 18
Form 4
+11.20%
10M
$1.00
$10,000,000.00
99.29M
Dec 18
Form 4
+19.05%
14.29M
$1.75
$24,999,999.50
89.29M
Jun 5
Form 3
0
0
No matching records found

Arbutus Biopharma Corp (ABUS) Snapshot price: $2.4912

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+142.59%
22.83M
38.85M
Oct 18
Form 4
0
0
Jan 12
Form 4
0
0
Oct 16
Form 3
0
0
No matching records found